ITUA20163037A1 - Formulazioni per uso nel trattamento o prevenzione di disturbi urologici - Google Patents
Formulazioni per uso nel trattamento o prevenzione di disturbi urologiciInfo
- Publication number
- ITUA20163037A1 ITUA20163037A1 ITUA2016A003037A ITUA20163037A ITUA20163037A1 IT UA20163037 A1 ITUA20163037 A1 IT UA20163037A1 IT UA2016A003037 A ITUA2016A003037 A IT UA2016A003037A IT UA20163037 A ITUA20163037 A IT UA20163037A IT UA20163037 A1 ITUA20163037 A1 IT UA20163037A1
- Authority
- IT
- Italy
- Prior art keywords
- formulations
- prevention
- treatment
- urological disorders
- urological
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITUA2016A003037A ITUA20163037A1 (it) | 2016-04-29 | 2016-04-29 | Formulazioni per uso nel trattamento o prevenzione di disturbi urologici |
ES17726694T ES2903410T3 (es) | 2016-04-29 | 2017-04-20 | Formulaciones para su uso en el tratamiento o en la prevención de enfermedades urológicas |
MA44769A MA44769B1 (fr) | 2016-04-29 | 2017-04-20 | Formulations destinées à une utilisation dans le traitement ou la prévention de maladies urologiques |
EP17726694.7A EP3448372B1 (en) | 2016-04-29 | 2017-04-20 | Formulations for use in the treatment or in the prevention of urological diseases |
PCT/IB2017/052268 WO2017187302A1 (en) | 2016-04-29 | 2017-04-20 | Formulations for use in the treatment or in the prevention of urological diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITUA2016A003037A ITUA20163037A1 (it) | 2016-04-29 | 2016-04-29 | Formulazioni per uso nel trattamento o prevenzione di disturbi urologici |
Publications (1)
Publication Number | Publication Date |
---|---|
ITUA20163037A1 true ITUA20163037A1 (it) | 2017-10-29 |
Family
ID=56801700
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITUA2016A003037A ITUA20163037A1 (it) | 2016-04-29 | 2016-04-29 | Formulazioni per uso nel trattamento o prevenzione di disturbi urologici |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3448372B1 (it) |
ES (1) | ES2903410T3 (it) |
IT (1) | ITUA20163037A1 (it) |
MA (1) | MA44769B1 (it) |
WO (1) | WO2017187302A1 (it) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109745291A (zh) * | 2019-03-07 | 2019-05-14 | 康赋葆(深圳)生物医药科技有限公司 | 一种增加姜黄素或其类似物生物利用度的纳米晶肠溶组合物及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006087759A2 (en) * | 2005-02-21 | 2006-08-24 | Safi Investment Holding Ag | Pharmaceutical composition comprising curcumin and resveratrol and uses thereof in medical field |
US20080044496A1 (en) * | 2006-08-03 | 2008-02-21 | Jose Angel Olalde Rangel | Arthritis phyto-nutraceutical synergistic composition |
US20080248129A1 (en) * | 2007-04-05 | 2008-10-09 | Pmc Formulas, Inc. | Compounds and methods for promoting cellular health and treatment of cancer |
WO2014165971A1 (en) * | 2013-04-10 | 2014-10-16 | Glycobiosciences, Inc. | Topical nutraceutical composition |
-
2016
- 2016-04-29 IT ITUA2016A003037A patent/ITUA20163037A1/it unknown
-
2017
- 2017-04-20 ES ES17726694T patent/ES2903410T3/es active Active
- 2017-04-20 MA MA44769A patent/MA44769B1/fr unknown
- 2017-04-20 EP EP17726694.7A patent/EP3448372B1/en active Active
- 2017-04-20 WO PCT/IB2017/052268 patent/WO2017187302A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006087759A2 (en) * | 2005-02-21 | 2006-08-24 | Safi Investment Holding Ag | Pharmaceutical composition comprising curcumin and resveratrol and uses thereof in medical field |
US20080044496A1 (en) * | 2006-08-03 | 2008-02-21 | Jose Angel Olalde Rangel | Arthritis phyto-nutraceutical synergistic composition |
US20080248129A1 (en) * | 2007-04-05 | 2008-10-09 | Pmc Formulas, Inc. | Compounds and methods for promoting cellular health and treatment of cancer |
WO2014165971A1 (en) * | 2013-04-10 | 2014-10-16 | Glycobiosciences, Inc. | Topical nutraceutical composition |
Non-Patent Citations (1)
Title |
---|
SU KANG KIM ET AL: "Inhibitory effect of curcumin on testosterone induced benign prostatic hyperplasia rat model", BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, vol. 39, no. 1, 22 October 2015 (2015-10-22), pages 69, XP055328092, DOI: 10.1002/biof.1066 * |
Also Published As
Publication number | Publication date |
---|---|
EP3448372A1 (en) | 2019-03-06 |
MA44769A (fr) | 2019-03-06 |
MA44769B1 (fr) | 2022-04-29 |
EP3448372B1 (en) | 2021-10-20 |
ES2903410T3 (es) | 2022-04-01 |
WO2017187302A1 (en) | 2017-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2548873B (en) | Use of Cannabidiol in the Treatment of SturgeWeber Syndrome | |
DK3481846T3 (da) | 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande | |
DK3882250T3 (da) | Tetrahydropyranyl-amino-pyrrolopyrimidinon til anvendelse i behandling af btk-medierede forstyrrelser | |
IL267649B (en) | Compounds and methods for treating chronic pain | |
DK3532067T3 (da) | Liposomal formulering til anvendelse til behandling af cancer | |
IT201600121601A1 (it) | Composizione orale per il trattamento del reflusso gastroesofageo e del reflusso laringo-faringeo | |
IL263477A (en) | Compositions and methods for the treatment or prevention of oxalate-related disorders | |
DK3153511T3 (da) | 2-acylaminothiazolderivat til anvendelse i forebyggelsen eller behandlingen af blære- og urinvejssygdomme | |
FR3022139B1 (fr) | Nouvelles compositions pour le traitement des rougeurs cutanees et de la rosacee | |
DK3307277T3 (da) | Enkeltstrengede oligonukleotider til anvendelse i medicinsk behandling af hudlidelser | |
IT201600081379A1 (it) | Composizione farmaceutica per uso nel trattamento delle patologie prostatiche. | |
DK3452465T3 (da) | Substituerede 2,4-diaminoquinolinderivater til anvendelse til behandling af proliferative sygdomme | |
DK3442547T3 (da) | Lactobacillus reuteri MM4-1A til anvendelse i behandling eller forebyggelse af autismespektrumforstyrrelser | |
IT201700121764A1 (it) | Composizione per il trattamento e/o la prevenzione di patologie neurodegenerative. | |
IT201600130012A1 (it) | Composizione per uso nel trattamento di disturbi dell'apparato uro-genitale | |
ITUA20161865A1 (it) | Uso di lentinano per il trattamento e la prevenzione di endometriosi. | |
CY1119674T1 (el) | Θεραπεια και προληψη της νοσου αλτσχαϊμερ (ad) | |
IT201700111939A1 (it) | Composizione farmaceutica per l’uso nel trattamento di stati infiammatori | |
ITUA20163037A1 (it) | Formulazioni per uso nel trattamento o prevenzione di disturbi urologici | |
IT201700038005A1 (it) | Dispositivo per la somministrazione di sostanze | |
ZA202006886B (en) | R-fadrozole for use in the treatment of aldostonerism | |
IL273863B1 (en) | Hemorrhoid treatment device | |
ZA201806894B (en) | (+)-azasetron for use in the treatment of ear disorders | |
GB2581876B (en) | Compositions for use in the treatment of endometrial disorder | |
IT201700090582A1 (it) | Composizione per l’uso nella prevenzione e/o nel trattamento di disturbi gastrici o gastroesofagei. |